What is it about?
We are evaluating the present possibilities to treat lymphedema by growing new lymphatic vessels (either inside the patient or outside the patient with following implantation).
Why is it important?
Lymphedema has no causal treatment. The standard of care is symptomatic treatment using complex decongestive therapy (CDT). CDT is successful in managing the symptoms, but does not address the underlying problem. The underlying problem are nonfunctional and/or underdeveloped lymphatic vessels. Growing new functional lymphatic vessels in patients or in the laboratory (using e.g. lymphatic growth factors such as VEGF-C) could solve this problem.
Read the Original
This page is a summary of: Lymphatic Vessels in Regenerative Medicine and Tissue Engineering, Tissue Engineering Part B Reviews, October 2016, Mary Ann Liebert Inc, DOI: 10.1089/ten.teb.2016.0034.
You can read the full text:
The following have contributed to this page